Clinical and Molecular Hepatology (Clin Mol Hepatol, CMH)

Correspondence

Correspondence on Letter regarding “Waiting for the changes after the adoption of steatotic liver disease”

Eileen L. Yoon, Dae Won Jun

Clin Mol Hepatol. 2024;30(1):126-128. Published online November 28, 2023

DOI: https://doi.org/10.3350/cmh.2023.0500

View: 1082 Download: 33

Review

Risk factors in nonalcoholic fatty liver disease

Eunji Ko, Eileen L. Yoon, Dae Won Jun

Clin Mol Hepatol. 2023;29(Suppl):S79-S85. Published online December 14, 2022

DOI: https://doi.org/10.3350/cmh.2022.0398

View: 4062 Download: 222 Web of Science: 15 Crossref: 18

Correspondence

Correspondence on Letter regarding “Risk factors in nonalcoholic fatty liver disease”

Eileen L. Yoon, Dae Won Jun

Clin Mol Hepatol. 2023;29(4):1050-1051. Published online August 29, 2023

DOI: https://doi.org/10.3350/cmh.2023.0310

View: 1307 Download: 34

Special Review

Waiting for the changes after the adoption of steatotic liver disease

Eileen L. Yoon, Dae Won Jun

Clin Mol Hepatol. 2023;29(4):844-850. Published online September 6, 2023

DOI: https://doi.org/10.3350/cmh.2023.0291

View: 1974 Download: 160 Web of Science: 4 Crossref: 11

Original Article

Discovery of dipeptidyl peptidase-4 inhibitor specific biomarker in non-alcoholic fatty liver disease mouse models using modified basket trial

Ju Hee Oh, Dae Won Jun, Hye Young Kim, Seung Min Lee, Eileen L. Yoon, Jungwook Hwang, Jung Hwan Park, Hanbi Lee, Wankyu Kim, Hyunsung Kim

Clin Mol Hepatol. 2022;28(3):497-509. Published online April 28, 2022

DOI: https://doi.org/10.3350/cmh.2022.0019

View: 5430 Download: 164 Web of Science: 6 Crossref: 4

Review

Therapeutic mechanisms and beneficial effects of non-antidiabetic drugs in chronic liver diseases

Han Ah Lee, Young Chang, Pil Soo Sung, Eileen L. Yoon, Hye Won Lee, Jeong-Ju Yoo, Young-Sun Lee, Jihyun An, Do Seon Song, Young Youn Cho, Seung Up Kim, Yoon Jun Kim

Clin Mol Hepatol. 2022;28(3):425-472. Published online July 1, 2022

DOI: https://doi.org/10.3350/cmh.2022.0186

View: 6955 Download: 357 Web of Science: 12 Crossref: 13

Editorial

A need for patient-centered care in managing patients with liver cirrhosis

Eileen L. Yoon

Clin Mol Hepatol. 2021;27(2):270-272. Published online January 27, 2021

DOI: https://doi.org/10.3350/cmh.2021.0001

View: 3358 Download: 105 Web of Science: 2 Crossref: 2

Original Article

Acute-on-chronic liver failure as a major predictive factor for mortality in patients with variceal bleeding

Jongbeom Shin, Jung Hwan Yu, Young-Joo Jin, Hyung Joon Yim, Young Kul Jung, Jin Mo Yang, Do Seon Song, Young Seok Kim, Sang Gyune Kim, Dong Joon Kim, Ki Tae Suk, Eileen L. Yoon, Sang Soo Lee, Chang Wook Kim, Hee Yeon Kim, Jae Young Jang, Soung Won Jeong

Clin Mol Hepatol. 2020;26(4):540-553. Published online September 17, 2020

DOI: https://doi.org/10.3350/cmh.2020.0034

View: 6386 Download: 181 Web of Science: 23 Crossref: 23

Review

Comparison of clinical practice guidelines for the management of chronic hepatitis B: When to start, when to change, and when to stop

Hyung Joon Yim, Ji Hoon Kim, Jun Yong Park, Eileen L. Yoon, Hana Park, Jung Hyun Kwon, Dong Hyun Sinn, Sae Hwan Lee, Jeong-Hoon Lee, Hyun Woong Lee

Clin Mol Hepatol. 2020;26(4):411-429. Published online August 28, 2020

DOI: https://doi.org/10.3350/cmh.2020.0049

View: 14405 Download: 1,426 Web of Science: 63 Crossref: 64

Current status and strategies for the control of viral hepatitis A in Korea

Eileen L. Yoon, Dong Hyun Sinn, Hyun Woong Lee, Ji Hoon Kim

Clin Mol Hepatol. 2017;23(3):196-204. Published online September 19, 2017

DOI: https://doi.org/10.3350/cmh.2017.0034

View: 8918 Download: 206 Web of Science: 18 Crossref: 19

Case Report

Severe ischemic bowel necrosis caused by terlipressin during treatment of hepatorenal syndrome

Hae Rim Kim, Young Sun Lee, Hyung Joon Yim, Hyun Joo Lee, Ja Young Ryu, Hyun Jung Lee, Eileen L. Yoon, Sun Jae Lee, Jong Jin Hyun, Sung Woo Jung, Ja Seol Koo, Rok Sun Choung, Sang Woo Lee, Jai Hyun Choi

Clin Mol Hepatol. 2013;19(4):417-420. Published online December 28, 2013

DOI: https://doi.org/10.3350/cmh.2013.19.4.417

View: 7852 Download: 109 Crossref: 6

A case of necrotizing pancreatitis subsequent to transcatheter arterial chemoembolization in a patient with hepatocellular carcinoma

Song-I Bae, Jong Eun Yeon, Jong Mee Lee, Ji Hoon Kim, Hyun Jung Lee, Sun Jae Lee, Sang Jun Suh, Eileen L. Yoon, Hae Rim Kim, Kwan Soo Byun, Tae-Seok Seo

Clin Mol Hepatol. 2012;18(3):321-325. Published online September 25, 2012

DOI: https://doi.org/10.3350/cmh.2012.18.3.321

View: 7641 Download: 63 Crossref: 16

Clinical courses after administration of oral corticosteroids in patients with severely cholestatic acute hepatitis A; three cases

Eileen L. Yoon, Hyung Joon Yim, Seung Young Kim, Jeong Han Kim, Ju-Han Lee, Young Sun Lee, Hyun Jung Lee, Sung Woo Jung, Sang Woo Lee, Jai Hyun Choi

Clin Mol Hepatol. 2010;16(3):329-333. Published online September 30, 2010

DOI: https://doi.org/10.3350/kjhep.2010.16.3.329

View: 7023 Download: 85 Crossref: 7

1 |

Viewed By 5265	Prognostic value of ultra-low-pass whole-genome sequencing of circulating tumor DNA in hepatocellular carcinoma under systemic treatment
Viewed By 5212	MAFLD: How is it different from NAFLD?
Viewed By 5114	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Viewed By 3834	2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Viewed By 3767	Global incidence and prevalence of nonalcoholic fatty liver disease

Cited By 114	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Cited By 103	2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Cited By 76	Global incidence and prevalence of nonalcoholic fatty liver disease
Cited By 65	Forecasted 2040 global prevalence of nonalcoholic fatty liver disease using hierarchical bayesian approach
Cited By 52	MAFLD: How is it different from NAFLD?

Search